A New You in '22?

Quote

anonymous said:
Are you coming at the Fellows program? They have allowed for consistent market share growth as the other companies are sucking wind.
Click to expand...
Not at all. It’s clearly the best program in the industry. My point is that only a barely measurable market share growth has been realized over past decade. Yes, certain product segments have seen growth but that’s to be expected with niche technology. Again, for all the investment and upgrading, total market share growth is almost nonexistent.
 


anonymous said:
Not at all. It’s clearly the best program in the industry. My point is that only a barely measurable market share growth has been realized over past decade. Yes, certain product segments have seen growth but that’s to be expected with niche technology. Again, for all the investment and upgrading, total market share growth is almost nonexistent.
Click to expand...

You sound like an idiot. If you are talking about revenue growth in a declining market then that is simply market share growth. Biotronik is doing well. Go back to your troll hole
 


anonymous said:
You sound like an idiot. If you are talking about revenue growth in a declining market then that is simply market share growth. Biotronik is doing well. Go back to your troll hole
Click to expand...
Share growth in declining market leveraging an employment base that has contracted 25% in the past 2 years is not the example of a company that is “doing well”. Sounds like a company on the short path to obsolescence.
 


anonymous said:
Share growth in declining market leveraging an employment base that has contracted 25% in the past 2 years is not the example of a company that is “doing well”. Sounds like a company on the short path to obsolescence.
Click to expand...
Show me BIO share growth lasting more than a quarter over the last 3 years. Single chamber pacers? Nope, that market keeps sliding toward Micra. Duals? No game there either breaking into dual vendor agreements which are the most common these days. ICD, CRT, CRT-P? Where’s the BIO growth? I’ll give you ICM growth but thats only because the total ICM market is growing but that trend is forecast to reverse by 2024 and the market is becoming flooded and ASPs are dropping fast. It’s a death spiral.
 


anonymous said:
Show me BIO share growth lasting more than a quarter over the last 3 years. Single chamber pacers? Nope, that market keeps sliding toward Micra. Duals? No game there either breaking into dual vendor agreements which are the most common these days. ICD, CRT, CRT-P? Where’s the BIO growth? I’ll give you ICM growth but thats only because the total ICM market is growing but that trend is forecast to reverse by 2024 and the market is becoming flooded and ASPs are dropping fast. It’s a death spiral.
Click to expand...
 















Write your reply...
Top Bottom
Back
Quote